Pluristem Therapeutics CEO Zami Aberman's 2010 pay slips 4% to $559K
Pluristem Therapeutics reports 2010 executive compensation
By ExecPay News
Published: April 15, 2011
Pluristem Therapeutics reported fiscal year 2010 executive compensation information on April 15, 2011.
In 2010, two executives at Pluristem Therapeutics received on average a compensation package of $424K, a 6% decrease compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Zami Aberman, Chief Executive Officer, received $559K in total, which decreased by 4% compared to 2009. 59% of Aberman's compensation, or $332K, was in salary. Aberman also received $227K in stock awards.
Yaky Yanay, Chief Financial Officer, received a compensation package of $289K, which decreased by 9% compared to previous year. 55% of the compensation package, or $160K, was in salary.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on April 15, 2011.